Bio-Techne (TECH) Accounts Payables (2010 - 2026)

Bio-Techne has reported Accounts Payables for 17 years, with the latest figure at $23.5 million in Q1 2026.

• For the quarter ending Q1 2026, Accounts Payables fell 25.77% year-over-year to $23.5 million; the trailing twelve-month figure through Mar 2026 stood at $23.5 million (down 25.77% YoY), and the FY2025 full-year result was $25.3 million, down 33.34% from the prior year.
• Accounts Payables for Q1 2026 stood at $23.5 million, down from $26.3 million in the prior quarter.
• The five-year high for Accounts Payables was $38.0 million in Q2 2024, with the low at $23.5 million in Q1 2026.
• Average Accounts Payables over 5 years is $29.4 million, with a median of $30.2 million recorded in 2025.
• Year-over-year, Accounts Payables jumped 47.86% in 2024 and slumped 33.34% in 2025.
• Tracing TECH's Accounts Payables over 5 years: stood at $24.1 million in 2022, then soared by 30.76% to $31.5 million in 2023, then climbed by 5.1% to $33.1 million in 2024, then fell by 20.69% to $26.3 million in 2025, then dropped by 10.58% to $23.5 million in 2026.
• The last three Accounts Payables figures came in at $23.5 million (Q1 2026), $26.3 million (Q4 2025), and $30.2 million (Q3 2025), per Business Quant data.

Peer Comparison